Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
J Immunol
    August 2026
  1. ACKLAND J, Barozi V, Penrice-Randal R, Hartley C, et al
    Identifying molecular signatures underpinning treatment responses to novel therapeutics influencing COVID-19 outcomes.
    J Immunol. 2026;215:vkag189.
    >> Share

  2. SILVA JDC, Almeida C, Silva BMS, Bonfim BS, et al
    Elastase and myeloperoxidase participate in neutrophil extracellular trap release stimulated by SARS-CoV-2.
    J Immunol. 2026;215:vkaf313.
    >> Share

  3. MCKERNAN KE, Cephus JY, Kuehnle SN, Henriquez-Pilier E, et al
    Deficiency in circulating T cells in four core genotypes mice with Sry translocation.
    J Immunol. 2026;215:vkag207.
    >> Share

  4. DICK JK, Krishna VD, Hicks D, Sangala JA, et al
    ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2.
    J Immunol. 2026;215:vkag235.
    >> Share

    July 2026
  5. CHEUNG MW, Choi JD, Stempak JM, Chandran V, et al
    T cell immunity to SARS-CoV-2 vaccination in inflammatory bowel disease patients treated with anti-cytokine biologics.
    J Immunol. 2026;215:vkag173.
    >> Share

  6. NELSON SA, Rattan A, Marathe B, White CL, et al
    Distinct kinetic features of innate and adaptive responses in influenza A versus influenza B-infected mice.
    J Immunol. 2026;215:vkag196.
    >> Share

    May 2026
  7. SAIDU A, Crawford JC, Walden S, Qu JH, et al
    Highly focused human CD8+ T-cell response in the lower airways during acute influenza infection.
    J Immunol. 2026;215:vkag068.
    >> Share

  8. WANG Q, McManus LR, Levine KS, Blanc R, et al
    A multiplexed, systems-based approach for prediction of antibody neutralization breadth for soluble human receptors.
    J Immunol. 2026;215:vkag106.
    >> Share

    April 2026
  9. BENEZECH S, Picq L, Villard M, Rousseaux N, et al
    Single-cell analysis identifies CPT1a-associated metabolic remodeling in human NK cells during COVID-19.
    J Immunol. 2026;215:vkag036.
    >> Share

    March 2026
  10. VAHED H, Chentoufi AA, Prakash S, Quadiri A, et al
    CXCL13/CXCR5 chemokine axis promotes antiviral CXCR5+CD19+ B Cells and follicular/effector CXCR5+CD4+ T Cells in the lungs associated with protection from severe and fatal COVID-19 following infection with pathogenic SARS-CoV-2 Delta variant.
    J Immunol. 2026;215:vkag017.
    >> Share

  11. HANSEN MR, Sedney CJ, Xiao S, Prasad DBR, et al
    Adult mice with neonatal-like T cell subsets exhibit increased susceptibility to Bordetella pertussis and influenza infection.
    J Immunol. 2026;215:vkaf361.
    >> Share

    February 2026
  12. CONDE L, Oliveira DL, Maciel G, Castro F, et al
    Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discovery.
    J Immunol. 2026;215:vkaf305.
    >> Share

  13. APPS R, Polanco JJ, Lowman KE, Wang L, et al
    Leveraging optimized oligonucleotide-tagged antigen assemblies and single-cell sequencing for multiplexed proteogenomic profiling of human B cell reactivities.
    J Immunol. 2026;215:vkaf301.
    >> Share

  14. WERNINGHAUS IC, Hinke DM, Katta K, Bogen B, et al
    A combinatorial DNA vaccine encoding APC-targeted, bivalent HA and NA antigens results in an improved influenza vaccine.
    J Immunol. 2026;215:vkaf378.
    >> Share

  15. SHARMA SB, Kumar K, Parchment N, Eggleston T, et al
    Viral-specific induction of cellular and soluble urokinase plasminogen activator receptor (suPAR) expression.
    J Immunol. 2026;215:vkaf365.
    >> Share

  16. SOUDANI N, Sidney J, Da Silva Antunes R, Case JB, et al
    Identification of immunodominant T cell epitopes in SARS-CoV-2 spike protein in Syrian hamsters.
    J Immunol. 2026;215:vkaf342.
    >> Share

    December 2025
  17. LOPEZ ZAPANA PA, Shook LL, Joughin BA, Jasset OJ, et al
    Maternal proteome profiling reveals dynamic gestational age-specific responses to de novo vaccination.
    J Immunol. 2025 Dec 12:vkaf298. doi: 10.1093.
    >> Share

  18. ALBE JR, Chaudhary A, Khanna A, Weinstein K, et al
    Divergent effects of a Treg-selective IL-2 mutein on influenza-specific T cell responses.
    J Immunol. 2025 Dec 10:vkaf297. doi: 10.1093.
    >> Share

  19. ABE K, Holmes TH, Nguyen TT, Kim-Schulze S, et al
    Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study.
    J Immunol. 2025;214:3310-3320.
    >> Share

  20. OSUAGWU AE, Payne M, Bosch J, Mbonye U, et al
    Non-neutralizing antibodies against SARS-CoV-2 nucleocapsid protein mediate variant transcendent antibody-dependent cellular cytotoxicity.
    J Immunol. 2025;214:3385-3398.
    >> Share

  21. CHEN Y, Szelinski F, Ferreira-Gomes M, Durek P, et al
    Distinct expression of CD56 and CD19 marks molecular and functional endotypes of tetanus- versus RBD-specific human bone marrow plasma cells.
    J Immunol. 2025;214:3453-3464.
    >> Share

    October 2025
  22. DEVITO L, Mohanraj OS, Debnath D, Constantinesco NJ, et al
    Influenza infection exacerbates high-fat diet-induced atherosclerosis in apolipoprotein gene-deficient mice.
    J Immunol. 2025 Oct 30:vkaf276. doi: 10.1093.
    >> Share

  23. SILVA-MORAES V, Reis LR, Ross TM
    Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adults.
    J Immunol. 2025 Oct 30:vkaf286. doi: 10.1093.
    >> Share

  24. BRADLEY MC, Aliyu T, Gray J, Guan T, et al
    Dietary iron deficiency impairs effector function of memory T cells following influenza infection.
    J Immunol. 2025 Oct 29:vkaf291. doi: 10.1093.
    >> Share

    September 2025
  25. BYRNE J, Gaillard CM, Gu L, Garcia-Leon A, et al
    Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts.
    J Immunol. 2025;214:2238-2243.
    >> Share

    August 2025
  26. FENG Z, Han S, He Q, Zhao H, et al
    Chemokine (C-X-C motif) ligand 11 is a crucial antiviral modulator that affects viral replication, the IFN-gamma response, and T-cell functions during respiratory syncytial virus infection.
    J Immunol. 2025;214:1982-1999.
    >> Share

    July 2025
  27. AGRAFIOTIS A, Kuhn R, Panetti C, Venerito M, et al
    Clonally expanded IgG, but not IgA, antibody-secreting cells preferentially target influenza nucleoprotein following homologous and heterologous infections.
    J Immunol. 2025 Jul 26:vkaf144. doi: 10.1093.
    >> Share

    June 2025
  28. YANG OO
    The immunopathogenesis of SARS-CoV-2 infection: Overview of lessons learned in the first 5 years.
    J Immunol. 2025;214:1095-1104.
    >> Share

    May 2025
  29. ALLEN JD, Medina JM, Thomas MH, Lynch A, et al
    H3 hemagglutinin proteins optimized for 2018 to 2022 elicit neutralizing antibodies across panels of modern influenza A(H3N2) viruses.
    J Immunol. 2025 May 21:vkaf092. doi: 10.1093.
    >> Share

  30. NOURI HR, Schaunaman N, Kraft M, Numata M, et al
    Tollip deficiency enhances mitophagy and reduces STING activation in influenza A virus-infected mice.
    J Immunol. 2025 May 16:vkaf058. doi: 10.1093.
    >> Share

    April 2025
  31. MADRID DMC, Gu W, Karim SJI, Lowke MT, et al
    Single-cell analysis of pig lung leukocytes and their response to influenza infection and oseltamivir therapy.
    J Immunol. 2025 Apr 15:vkaf032. doi: 10.1093.
    >> Share

  32. DING C, Chen Q, Shi Y, Liu J, et al
    Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccination.
    J Immunol. 2025 Apr 15:vkae040. doi: 10.1093.
    >> Share

  33. HATIPOGLU I, Ainsua-Enrich E, Kadel S, Turner S, et al
    IRF4-regulated transcriptional and functional heterogeneity of lung-resident CD11b+ cDC2 subsets during influenza virus infection.
    J Immunol. 2025 Apr 10:vkaf060. doi: 10.1093.
    >> Share

  34. DINANT S, Castille J, Deloizy C, Bruder E, et al
    The prion-family protein Doppel exerts a protective role during influenza virus infection.
    J Immunol. 2025 Apr 9:vkaf031. doi: 10.1093.
    >> Share

    March 2025
  35. RAO AS, Ugwu N, Onufer AP, Kumova O, et al
    Cathelicidin-related antimicrobial peptide (CRAMP) is toxic during neonatal murine influenza virus infection.
    J Immunol. 2025 Mar 18:vkae053. doi: 10.1093.
    >> Share

  36. KHAN R, Ji W, Guzman Rivera J, Madhvi A, et al
    A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome.
    J Immunol. 2025;214:373-383.
    >> Share

  37. BURMAS L, Lee WS, Kelly A, Webster R, et al
    Modulation of germinal center and antibody dynamics via ipsilateral versus contralateral immunization against SARS-CoV-2.
    J Immunol. 2025;214:335-346.
    >> Share

    February 2025
  38. WANG M, Liu C, Fan Q, Sun Y, et al
    Rapid clonal expansion and somatic hypermutation contribute to the fate of SARS-CoV-2 broadly neutralizing antibodies.
    J Immunol. 2025;214:278-289.
    >> Share

    January 2025
  39. GROVENSTEIN P, Bhatnagar N, Kim KH, Pal SS, et al
    Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered.
    J Immunol. 2025;214:104-114.
    >> Share

  40. QIAO P, Yue C, Peng W, Liu K, et al
    Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2.
    J Immunol. 2025;214:115-129.
    >> Share

    November 2024
  41. TONG X, Deng Y, Cizmeci D, Fontana L, et al
    Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.
    J Immunol. 2024 Nov 17:ji2200956. doi: 10.4049/jimmunol.2200956.
    >> Share

  42. DICK JK, Sangala JA, Krishna VD, Khaimraj A, et al
    NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children.
    J Immunol. 2024;213:1452-1466.
    >> Share

    October 2024
  43. RAJU N, Kramer KJ, Cavallaro M, Diotti RA, et al
    Multiplexed Antibody Sequencing and Profiling of the Human Hemagglutinin-specific Memory B Cell Response following Influenza Vaccination.
    J Immunol. 2024 Oct 23:ji2400326. doi: 10.4049/jimmunol.2400326.
    >> Share

    September 2024
  44. DRUSKOVIC M, Lucovnik M, Mesaric VA, Kavsek G, et al
    Immune Response to SARS-CoV-2 in Vaccine-naive Pregnant Women: Assessment of IgG and IgA Antibody Profile at Delivery and 42 Days Postpartum.
    J Immunol. 2024 Sep 11:ji2400055. doi: 10.4049/jimmunol.2400055.
    >> Share

  45. HOLDER KA, Ings DP, Fifield KE, Barnes DA, et al
    Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection.
    J Immunol. 2024 Sep 9:ji2400250. doi: 10.4049/jimmunol.2400250.
    >> Share

  46. IZADI A, Godzwon M, Soderlund Strand A, Schmidt T, et al
    Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence.
    J Immunol. 2024;213:678-689.
    >> Share

    June 2024
  47. HE Z, Li W, Zhang M, Huang M, et al
    RNF216 Inhibits the Replication of H5N1 Avian Influenza Virus and Regulates the RIG-I Signaling Pathway in Ducks.
    J Immunol. 2024 Jun 3:ji2300540. doi: 10.4049/jimmunol.2300540.
    >> Share

  48. LEIGHTON PA, Ching K, Reynolds K, Vuong CN, et al
    Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies.
    J Immunol. 2024;212:1744-1753.
    >> Share

  49. LEE MJ, de Los Rios Kobara I, Barnard TR, Vales Torres X, et al
    NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19.
    J Immunol. 2024;212:1693-1705.
    >> Share

    May 2024
  50. BOUCHER J, Gilbert C, Bose S, Tessier PA, et al
    S100A9: The Unusual Suspect Connecting Viral Infection and Inflammation.
    J Immunol. 2024;212:1523-1529.
    >> Share

  51. SAITO S, Bozorgmehr N, Sligl W, Osman M, et al
    The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease.
    J Immunol. 2024;212:1540-1552.
    >> Share

    April 2024
  52. BUDYLOWSKI P, Chau SLL, Banerjee A, Guvenc F, et al
    A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera.
    J Immunol. 2024 Apr 29:ji2300320. doi: 10.4049/jimmunol.2300320.
    >> Share

  53. KUNDURA L, Cezar R, Ballongue E, Andre S, et al
    Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency.
    J Immunol. 2024;212:1105-1112.
    >> Share

  54. ABE K, Beer JC, Nguyen T, Ariyapala IS, et al
    Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory Markers in a COVID-19 Cohort.
    J Immunol. 2024;212:1244-1253.
    >> Share

    March 2024
  55. LI W, Lin Y, Wang X, Yang H, et al
    Chicken UFL1 Restricts Avian Influenza Virus Replication by Disrupting the Viral Polymerase Complex and Facilitating Type I IFN Production.
    J Immunol. 2024 Mar 13:ji2300613. doi: 10.4049/jimmunol.2300613.
    >> Share

  56. READ KA, Amici SA, Farsi S, Cutcliffe M, et al
    PRMT5 Promotes T follicular helper Cell Differentiation and Germinal Center Responses during Influenza Virus Infection.
    J Immunol. 2024 Mar 4:ji2300270. doi: 10.4049/jimmunol.2300270.
    >> Share

  57. AL-AHMAD A
    Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2024;212:753.
    >> Share

  58. MAINO A, Amen A, Plumas J, Bouquet L, et al
    Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for the Expansion and Characterization of SARS-CoV-2-Specific T Cells.
    J Immunol. 2024;212:825-833.
    >> Share

    February 2024
  59. TANDON P, Abrams ND, Avula LR, Carrick DM, et al
    Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report.
    J Immunol. 2024;212:505-512.
    >> Share

  60. BRADSHAW CM, Georgieva T, Tankersley TN, Taylor-Doyle T, et al
    Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
    J Immunol. 2024;212:523-528.
    >> Share

  61. DHANUSHKODI NR, Prakash S, Quadiri A, Zayou L, et al
    Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models.
    J Immunol. 2024;212:576-585.
    >> Share

  62. KAMMANN T, Gorin JB, Parrot T, Gao Y, et al
    Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies.
    J Immunol. 2024;212:389-396.
    >> Share

    November 2023
  63. LOBBY JL, Danzy S, Holmes KE, Lowen AC, et al
    Both Humoral and Cellular Immunity Limit the Ability of Live Attenuated Influenza Vaccines to Promote T Cell Responses.
    J Immunol. 2023 Nov 20:ji2300343. doi: 10.4049/jimmunol.2300343.
    >> Share

  64. EVANS JP, Liu SL
    Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies.
    J Immunol. 2023;211:1459-1467.
    >> Share

    October 2023
  65. MA W, Loving CL, Driver JP
    From Snoot to Tail: A Brief Review of Influenza Virus Infection and Immunity in Pigs.
    J Immunol. 2023;211:1187-1194.
    >> Share

  66. DIAZ FE, McGill JL
    Modeling Human Respiratory Syncytial Virus (RSV) Infection: Recent Contributions and Future Directions Using the Calf Model of Bovine RSV Disease.
    J Immunol. 2023;211:1180-1186.
    >> Share

  67. NOORUZZAMAN M, Diel DG
    Infection Dynamics, Pathogenesis, and Immunity to SARS-CoV-2 in Naturally Susceptible Animal Species.
    J Immunol. 2023;211:1195-1201.
    >> Share

  68. ROSENBERG-HASSON Y, Holmes TH, Diray-Arce J, Chen J, et al
    Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients.
    J Immunol. 2023;211:1224-1231.
    >> Share

    September 2023
  69. LUCKE J, Heinrich F, Malsy J, Meins N, et al
    Intestinal IL-1beta Plays a Role in Protecting against SARS-CoV-2 Infection.
    J Immunol. 2023;211:1052-1061.
    >> Share

    August 2023
  70. SANDBERG JK, Leeansyah E, Eller MA, Shacklett BL, et al
    The Emerging Role of MAIT Cell Responses in Viral Infections.
    J Immunol. 2023;211:511-517.
    >> Share

  71. CAO L, Hui X, Xu T, Mao H, et al
    The RNA-Splicing Ligase RTCB Promotes Influenza A Virus Replication by Suppressing Innate Immunity via Interaction with RNA Helicase DDX1.
    J Immunol. 2023 Aug 9:ji2200799. doi: 10.4049/jimmunol.2200799.
    >> Share

    July 2023
  72. YU H, Worrall LJ, Berger T, Petric M, et al
    Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2.
    J Immunol. 2023 Jul 26:ji2300282. doi: 10.4049/jimmunol.2300282.
    >> Share

  73. LAW JC, Watts TH
    Considerations for Choosing T Cell Assays during a Pandemic.
    J Immunol. 2023;211:169-174.
    >> Share

  74. PONDE NO, Shoger KE, Khatun MS, Sarkar MK, et al
    SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor.
    J Immunol. 2023;211:252-260.
    >> Share

    June 2023
  75. CHEUNG MW, Dayam RM, Shapiro JR, Law JC, et al
    Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
    J Immunol. 2023 Jun 16:ji2300190. doi: 10.4049/jimmunol.2300190.
    >> Share

  76. MAMBELLI F, Marinho FV, Andrade JM, de Araujo ACVSC, et al
    Recombinant Bacillus Calmette-Guerin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.
    J Immunol. 2023;210:1925-1937.
    >> Share

  77. PAIDI RK, Jana M, Raha S, Mishra RK, et al
    Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19.
    J Immunol. 2023;210:1938-1949.
    >> Share

  78. NAM H, Koh JY, Jung JH, Jeong H, et al
    Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19.
    J Immunol. 2023;210:1687-1699.
    >> Share

    May 2023
  79. PHAN JM, Layton ED, Yu KKQ, Aguilar MS, et al
    Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2.
    J Immunol. 2023;210:1236-1246.
    >> Share

    March 2023
  80. FINN CM, Dhume K, Prokop E, Strutt TM, et al
    STAT1 Controls the Functionality of Influenza-Primed CD4 T Cells but Therapeutic STAT4 Engagement Maximizes Their Antiviral Impact.
    J Immunol. 2023 Mar 24:ji2200407. doi: 10.4049/jimmunol.2200407.
    >> Share

  81. HEMANN EA, Knoll ML, Wilkins CR, Subra C, et al
    A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.
    J Immunol. 2023 Mar 20:ji2300026. doi: 10.4049/jimmunol.2300026.
    >> Share

  82. VAN DE WALL S, Crooks S, Varga SM, Badovinac VP, et al
    Cutting Edge: Influenza-Induced CD11alo Airway CD103+ Tissue Resident Memory T Cells Exhibit Compromised IFN-gamma Production after In Vivo TCR Stimulation.
    J Immunol. 2023 Mar 13:ji2200931. doi: 10.4049/jimmunol.2200931.
    >> Share

  83. ZHAO Y, Xiao W, Wu Y, Fan W, et al
    Parallel T Cell Immunogenic Regions in Influenza B and A Viruses with Distinct Nuclear Export Signal Functions: The Balance between Viral Life Cycle and Immune Escape.
    J Immunol. 2023 Mar 10:ji2200243. doi: 10.4049/jimmunol.2200243.
    >> Share

  84. SHAMSELDIN MM, Kenney A, Zani A, Evans JP, et al
    Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
    J Immunol. 2023 Mar 6:ji2200297. doi: 10.4049/jimmunol.2200297.
    >> Share

    February 2023
  85. QUINN M, Parra-Rodriguez L, Alsoussi WB, Ayres C, et al
    Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination.
    J Immunol. 2023 Feb 13:ji2200920. doi: 10.4049/jimmunol.2200920.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016